By year-end 2028, submit new drug application evaluating cemsidomide and dexamethasone for potential accelerated approval in fourth line or later. In Q2 2026, initiate the Phase 1b trial of ...
New CLASSIC technique uses AI and massive DNA libraries to predict genetic circuit performance faster and more accurately.
With its temperature of -50°C, the archive sanctuary built below the surface at Concordia will allow endangered ice cores ...